Opening question - ATTR-ACT Trial.

ATTR-ACT Trial - Efficacy and Safety of Tafamidis in Transthyretin Amyloid Cardiomyopathy

Discussant review - ATTR-ACT.

Questions from the audience and discussion.

Concluding question - ATTR-ACT Trial.

Opening question - COMMANDER HF.

COMMANDER HF - Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure

Discussant review - COMMANDER HF.

Questions from the audience and discussion.

Concluding question - COMMANDER HF.